IPCALAB.NS Forward P/E

The Forward P/E of IPCA Laboratories Ltd (IPCALAB.NS) is 37.52.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

IPCALAB.NS Forward P/E - Peers Comparison

Ticker	Name	Value
STAR.NS	Strides Pharma Science Ltd	15.57
ALKEM.NS	Alkem Laboratories Ltd	26.50
ERIS.NS	Eris Lifesciences Ltd	53.42
GLENMARK.NS	Glenmark Pharmaceuticals Ltd	27.75
PFIZER.NS	Pfizer Ltd	31.85
AARTIDRUGS.NS	Aarti Drugs Ltd	8.85
AJANTPHARM.NS	Ajanta Pharma Ltd	33.55
JBCHEPHARM.NS	J B Chemicals and Pharmaceuticals Ltd	34.73
TORNTPHARM.NS	Torrent Pharmaceuticals Ltd	56.13
PGHL.NS	Procter & Gamble Health Ltd	34.52
SOLARA.NS	Solara Active Pharma Sciences Ltd	26.39
CAPLIPOINT.NS	Caplin Point Laboratories Ltd	26.51
IOLCP.NS	IOL Chemicals and Pharmaceuticals Ltd	13.17
ABBOTINDIA.NS	Abbott India Ltd	44.41
APLLTD.NS	Alembic Pharmaceuticals Ltd	30.88
GLAND.NS	Gland Pharma Ltd	30.39
LAURUSLABS.NS	Laurus Labs Ltd	57.59
SUVENPHAR.NS	Suven Pharmaceuticals Ltd	75.40
ORCHPHARMA.NS	Orchid Pharma Ltd	40.51
SANOFI.NS	Sanofi India Ltd	32.63
GLAXO.NS	GlaxoSmithKline Pharmaceuticals Ltd	52.82
GRANULES.NS	Granules India Ltd	22.02
NATCOPHARM.NS	Natco Pharma Ltd	7.43